WDNA vs. SCHG
WDNA (WisdomTree BioRevolution Fund) and SCHG (Schwab U.S. Large-Cap Growth ETF) are both exchange-traded funds - WDNA is a Health & Biotech Equities fund tracking the WisdomTree BioRevolution Index, while SCHG is a Large Cap Growth Equities fund tracking the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. Both are passively managed. Over the past 5 years, WDNA returned -4.94%/yr vs 13.68%/yr for SCHG. A 0.60 correlation means they provide meaningful diversification when combined. WDNA charges 0.45%/yr vs 0.04%/yr for SCHG.
Performance
WDNA vs. SCHG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WDNA achieves a 12.77% return, which is significantly higher than SCHG's 2.76% return.
WDNA
- 1D
- 0.90%
- 1M
- 8.40%
- YTD
- 12.77%
- 6M
- 10.12%
- 1Y
- 49.11%
- 3Y*
- 5.29%
- 5Y*
- -4.94%
- 10Y*
- —
SCHG
- 1D
- -1.24%
- 1M
- -2.59%
- YTD
- 2.76%
- 6M
- 2.11%
- 1Y
- 20.89%
- 3Y*
- 22.70%
- 5Y*
- 13.68%
- 10Y*
- 18.81%
WDNA vs. SCHG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 12.77% | 22.68% | -14.18% | -2.07% | -26.29% | -4.92% |
SCHG Schwab U.S. Large-Cap Growth ETF | 2.76% | 17.50% | 34.95% | 50.10% | -31.80% | 19.86% |
Correlation
The correlation between WDNA and SCHG is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.46 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.49 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.61 |
Correlation (All Time) Calculated using the full available price history since Jun 3, 2021 | 0.60 |
The correlation between WDNA and SCHG shifts across timeframes, from 0.46 (1 year) to 0.60 (5 years), reflecting how their relationship changes across market environments.
WDNA vs. SCHG - Sectors Allocation Comparison
Sectors
WDNA
SCHG
Healthcare
Basic Materials
Consumer Defensive
Energy
Communication Services
-
Consumer Cyclical
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
WDNA
SCHG
Basic Materials
WDNA
SCHG
Consumer Defensive
WDNA
SCHG
Energy
WDNA
SCHG
Communication Services
WDNA
-
SCHG
Consumer Cyclical
WDNA
-
SCHG
Financial Services
WDNA
-
SCHG
Industrials
WDNA
-
SCHG
Real Estate
WDNA
-
SCHG
Technology
WDNA
-
SCHG
Utilities
WDNA
-
SCHG
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WDNA vs. SCHG — Risk / Return Rank
WDNA
SCHG
WDNA vs. SCHG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and Schwab U.S. Large-Cap Growth ETF (SCHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| WDNA | SCHG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.61 | ||
| Sortino ratioReturn per unit of downside risk | +0.94 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.23 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 4.22 | 1.28 | +2.94 |
| Martin ratioReturn relative to average drawdown | 9.45 | 4.19 | +5.27 |
Loading charts...
Drawdowns
WDNA vs. SCHG - Drawdown Comparison
The maximum WDNA drawdown since its inception was -58.87%, which is greater than SCHG's maximum drawdown of -34.59%. Use the drawdown chart below to compare losses from any high point for WDNA and SCHG.
Loading charts...
Drawdown Indicators
| WDNA | SCHG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.87% | -34.59% | -24.28% |
Max Drawdown (1Y)Largest decline over 1 year | -11.70% | -16.41% | +4.71% |
Max Drawdown (3Y)Largest decline over 3 years | -38.25% | -23.39% | -14.86% |
Max Drawdown (5Y)Largest decline over 5 years | -58.87% | -34.59% | -24.28% |
Max Drawdown (10Y)Largest decline over 10 years | — | -34.59% | — |
Current DrawdownCurrent decline from peak | -27.41% | -5.16% | -22.25% |
Average DrawdownAverage peak-to-trough decline | -35.57% | -5.20% | -30.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.21% | 5.00% | +0.21% |
Volatility
WDNA vs. SCHG - Volatility Comparison
WisdomTree BioRevolution Fund (WDNA) has a higher volatility of 7.42% compared to Schwab U.S. Large-Cap Growth ETF (SCHG) at 5.78%. This indicates that WDNA's price experiences larger fluctuations and is considered to be riskier than SCHG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WDNA | SCHG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.42% | 5.78% | +1.64% |
Volatility (6M)Calculated over the trailing 6-month period | 16.98% | 12.50% | +4.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.95% | 16.21% | +9.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.14% | 22.37% | +2.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.07% | 21.61% | +3.46% |
WDNA vs. SCHG - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is higher than SCHG's 0.04% expense ratio.
Dividends
WDNA vs. SCHG - Dividend Comparison
WDNA's dividend yield for the trailing twelve months is around 4.05%, more than SCHG's 0.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SCHG Schwab U.S. Large-Cap Growth ETF | 0.38% | 0.36% | 0.39% | 0.46% | 0.55% | 0.42% | 0.52% | 0.82% | 1.27% | 1.01% | 1.04% | 1.22% |
WDNA WisdomTree BioRevolution Fund | 4.05% | 4.57% | 0.75% | 0.80% | 0.38% | 0.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
WDNA and SCHG have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
WDNA has higher volatility (7.42%) compared to SCHG (5.78%). In terms of maximum drawdown, WDNA dropped -58.87% vs SCHG's -34.59%.
On 5-year performance, SCHG leads with 13.68% vs -4.94% for WDNA. On fees, SCHG is cheaper at 0.04% per year. On volatility, SCHG has been the lower-risk option at 5.78%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, SCHG has performed better with a 13.68% return vs -4.94%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SCHG is cheaper with a 0.04% expense ratio, compared with 0.45% for WDNA.
WDNA has the higher dividend yield at 4.05%, compared with 0.38% for SCHG.
WDNA is categorized as Health & Biotech Equities, while SCHG is Large Cap Growth Equities. WDNA tracks WisdomTree BioRevolution Index, while SCHG tracks Dow Jones U.S. Large-Cap Growth Total Stock Market Index. They also come from different issuers: WisdomTree and Charles Schwab. Their fees differ too: 0.45% for WDNA and 0.04% for SCHG.
WDNA currently has the higher Sharpe Ratio (1.91 vs 1.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WDNA and SCHG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer